FEED PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d

FEED ▼ -18.55% at T+5d

NEUTRAL call ✗ call lost -18.55% · α vs SPY -18.63% · entry $1.24 → $1.01

Next anchor: T+20d due 3d ago

Currently $0.8290 · -33.15% from $1.24 entry

Entry anchored
May 12, 08:31 AM ET
via Databento tick

T+1d

-6.45%

call -6.45% · α -7.03%

$1.16

settled 4w ago

T+5d

-18.55%

call -18.55% · α -18.63%

$1.01

settled 25d ago

T+20d

—

call — · α —

—

due 3d ago

T+60d

—

call — · α —

—

in 8w

Price Chart

Loading chart...

Executive Summary

ENvue Medical announced a three-year contract renewal by a leading integrated nonprofit health system operating 12 hospitals across Virginia and North Carolina, with the ENvue Navigation Platform adopted as the standardized protocol for bedside enteral feeding tube placement across all hospitals in the network. This renewal extends the relationship through 2028 and represents a shift from contracted access to embedded clinical workflow, which the company believes provides a replicable model for expansion to other health systems. No financial terms of the contract were disclosed.

Actionable Insight

The contract renewal is a positive commercial validation for a small-cap medtech company, but the lack of disclosed financial terms limits the immediate stock-moving potential. Monitor for future announcements of similar standardization agreements with other health systems, which could signal revenue acceleration. The company's $5M market cap means even modest contract wins could have outsized impact, but without dollar figures, the near-term catalyst is unclear.

Key Facts

Three-year contract renewal by a leading integrated nonprofit health system operating 12 hospitals across Virginia and North Carolina.
ENvue Navigation Platform adopted as the standardized protocol for bedside enteral feeding tube placement across all hospitals within the network.
Renewal extends the relationship through 2028.
No financial terms (dollar amount, revenue contribution) were disclosed in the press release.
Company has a market cap of $5M and is a commercial-stage medical device company.

Financial Impact

Undisclosed — no contract value or revenue contribution provided.

revenue

Risk Factors

No financial terms disclosed — contract may be immaterial to revenue.
Company is commercial-stage with a $5M market cap, indicating limited revenue base and potential cash burn.
Forward-looking statements about expansion are aspirational and not guaranteed.
Competition in the medical device space for enteral feeding tube placement.

Market Snapshot

Exchange

Nasdaq

Sector

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Analyst Consensus

86% bullish (7 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3292861

4 reports for FEED

T+1T+5T+20T+60

67% Hit rate 2 of 3 directional calls best @ T+5▲ +3.66%May 29, 2026

Filters

Reports for FEED — sortable, filterable
	Type				Now
Jun 3, 2026 10d ago	Press Release BULLISH ★ 6/10	$0.8600 $0.8500	▼ −1.16%	▼ −1.56%	$0.8290 (−3.60%)
May 29, 2026 15d ago	EFFECT BEARISH ★ 7/10	$0.9020 $0.9040	▼ −0.22%	▲ +0.04%	$0.8290 (+8.09%)
May 18, 2026 25d ago	S-3 BEARISH ★ 7/10	$0.9300 $0.9310	▼ −0.11%	▲ +0.93%	$0.8290 (+10.86%)
May 12, 2026 4w ago	Press Release NEUTRAL ★ 4/10	$1.24 $1.16	▼ −6.45%	▼ −7.03%	$0.8290 (−33.15%)

US Market Status

Market Closed — Opens Mon (48h 48m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access